Pembrolizumab,Atezolizumab,Cabozantinib
Merck,ROCHE
['kidney cancer', 'keytruda', 'tecentriq', 'lung', 'roche,(-broche),(-rocheter)', 'merck']
asco: merck's keytruda trips in egfr lung cancer as roche's tecentriq fails in kidney cancer 
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.